osimertinib
astrazeneca
['adaura', 'lcsm,(-blcsm)', 'aura ,(-laura)']
#esmo22 #lcsm adaura updates using osi in adjuvant setting 4-yrs hr stage ii 0.23 (maturity 51%: 32% osi, 70% placebo) *from the km curves, it seems that we are preventing and not curing! 
Thoracic oncologist & researcher @IEOufficiale; @myESMO Press & Media Chair; #LungCancer Molecular target-believer #LCSM